source
- After billions in deals, Insilico CEO promises: ‘You haven't seen anything yet’Insilico Medicine CEO Alex Zhavoronkov’s mad dash across the BIO International Convention in June attracted plenty of eyes. But the executive would prefer industry watchers gawk at the billions of…BioSpace · 7h ago↗ source
- STAT+: Skylark Bio kicks off new gene therapy trial for deafnessBiotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.STAT · 7h ago↗ source
- AbCellera’s menopause medicine ‘sets new efficacy bar’ for hot flashesAbCellera Biologics’ reduction in hot flashes sets it apart from currently commercial oral drugs, including Astellas’ Veozah and Bayer’s Lynkuet, according to BMO Capital Markets.